METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Clinical trials for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Finland's prostate cancer patterns revealed in large data review
Knowledge-focused CompletedThis completed study looked at over 1,000 men with metastatic prostate cancer in the Pirkanmaa region of Finland. Researchers analyzed patient characteristics, treatments used, and outcomes to better understand the disease burden. The goal was to fill gaps in knowledge about how …
Matched conditions: METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Real-World data reveals treatment patterns for advanced prostate cancer
Knowledge-focused CompletedThis study reviewed medical records from over 1,300 men with metastatic prostate cancer that still responds to hormone therapy. Researchers wanted to see how long patients actually take the pills apalutamide or enzalutamide when prescribed by their own doctors in routine care. Th…
Matched conditions: METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC)
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC